|LoPhos is a powerful phosphate binder.|
|LoPhos is first choice for hyperphosphatemia in CKD patients.|
|Less hypercalcemic effects.|
Each tablet contains 667 mg of Calcium acetate, equal to 169 mg (8.45 mEq) elemental calcium.
INDICATIONS AND USAGE:
LoPhos is indicated for the control of hyperphosphatemia in end stage renal failure.
DOSAGE AND ADMINISTRATION Tablets:
The recommended initial dose of LoPhos for the adult dialysis patient is 2 tablets with each meal. The dosage may be increased gradually to bring the serum value below 6 mg/dl, as long as hypercalcemia does not develop. Most patients require 3-4 tablets with each meal.
LoPhos is available in blister pack of 10x10 Tablets.
Protect from heat, sunlight and moisture. Keep out of the reach of Children.